EPO and Parkinson disease: The neuroprotective effect of the TfRMAb-EPO fusion protein in experimental PD was tested in the mouse following the intra-cerebral injection of 6 ug of 6-hydroxydopamine in each of 2 regions of the right striatum (Zhou et al., 2011b).